Results
|
10041.
|
|
|
10042.
|
|
|
10043.
|
Daunorubicin in the therapy of acute granulocytic leukemia. [electronic resource] by
- Weil, M
- Glidewell, O J
- Jacquillat, C
- Levy, R
- Serpick, A A
- Wiernik, P H
- Cuttner, J
- Hoogstraten, B
- Wasserman, L
- Ellison, R R
- Gailani, S
- Brunner, K
- Silver, R T
- Rege, V B
- Cooper, M R
- Lowenstein, L
- Nissen, N I
- Haurani, F
- Blom, J
- Boiron, M
- Bernard, J
- Holland, J F
Producer: 19730709
In:
Cancer research vol. 33
Availability: No items available.
|
|
10044.
|
|
|
10045.
|
|
|
10046.
|
|
|
10047.
|
|
|
10048.
|
|
|
10049.
|
|
|
10050.
|
Mitoxantrone, etoposide, carboplatinum and ara-C combination therapy (MECA) in refractory and relapsed acute leukemia. [electronic resource] by
- Ferrá, C
- Berlanga, J J
- Gallardo, D
- Ancín, I
- Marín, D
- González, J R
- Peris, J
- Muñoz, J
- Sarrá, J
- Grañena, A
Producer: 20011004
In:
Leukemia & lymphoma vol. 39
Availability: No items available.
|
|
10051.
|
|
|
10052.
|
Immunophenotyping is an independent factor for risk stratification in AML. [electronic resource] by
- Repp, R
- Schaekel, U
- Helm, G
- Thiede, C
- Soucek, S
- Pascheberg, U
- Wandt, H
- Aulitzky, W
- Bodenstein, H
- Sonnen, R
- Link, H
- Ehninger, G
- Gramatzki, M
Producer: 20040220
In:
Cytometry. Part B, Clinical cytometry vol. 53
Availability: No items available.
|
|
10053.
|
|
|
10054.
|
Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia. [electronic resource] by
- Löwenberg, Bob
- van Putten, Wim
- Theobald, Matthias
- Gmür, Jurg
- Verdonck, Leo
- Sonneveld, Pieter
- Fey, Martin
- Schouten, Harry
- de Greef, Georgine
- Ferrant, Augustin
- Kovacsovics, Tibor
- Gratwohl, Alois
- Daenen, Simon
- Huijgens, Peter
- Boogaerts, Marc
Producer: 20030825
In:
The New England journal of medicine vol. 349
Availability: No items available.
|
|
10055.
|
Phase III trial of cyclophosphamide, epirubicin, fluorouracil (CEF) versus cyclophosphamide, mitoxantrone, fluorouracil (CNF) in women with metastatic breast cancer. [electronic resource] by
- Estaban, E
- Lacave, A J
- Fernández, J L
- Corral, N
- Buesa, J M
- Estrada, E
- Palacio, I
- Vieitez, J M
- Muñiz, I
- Alvarez, E
Producer: 20000407
In:
Breast cancer research and treatment vol. 58
Availability: No items available.
|
|
10056.
|
|
|
10057.
|
|
|
10058.
|
|
|
10059.
|
|
|
10060.
|
Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemia. [electronic resource] by
- Visani, G
- Milligan, D
- Leoni, F
- Chang, J
- Kelsey, S
- Marcus, R
- Powles, R
- Schey, S
- Covelli, A
- Isidori, A
- Litchman, M
- Piccaluga, P P
- Mayer, H
- Malagola, M
- Pfister, C
Producer: 20010531
In:
Leukemia vol. 15
Availability: No items available.
|